Oncotarget
ISSN: 1949-2553
Publisher: Impact Journals
Publications (110)
Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe (2017)
Becker JC, Lorenz E, Ugurel S, Eigentler TK, Kiecker F, Pfoehler C, Kellner I, et al.
Journal article
Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma (2017)
Florea AM, Varghese E, Mccallum JE, Mahgoub S, Helmy I, Varghese S, Gopinath N, et al.
Journal article
V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - A new option for HCC therapy (2017)
Bartel K, Winzi M, Ulrich M, Koeberle A, Menche D, Werz O, Mueller R, et al.
Journal article
Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma (2017)
Wittig-Blaich S, Wittig R, Schmidt S, Lyer S, Bewerunge-Hudler M, Gronert-Sum S, Strobel-Freidekind O, et al.
Journal article
Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas (2017)
Ackermann A, Capci Karagöz A, Ghoochani A, Buchfelder M, Eyüpoglu IY, Tsogoeva S, Savaskan N
Journal article
KIF3A and IL-4 are disease-specific biomarkers for psoriatic arthritis susceptibility (2017)
Cascella R, Strafella C, Ragazzo M, Manzo L, Costanza G, Bowes J, Hueffmeier U, et al.
Journal article
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017)
Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, et al.
Journal article
Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity (2017)
Fasching P, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, et al.
Journal article
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017)
Glubb DM, Johnatty SE, Quinn MCJ, O'Mara TA, Tyrer JP, Gao B, Fasching P, et al.
Journal article
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017)
Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al.
Journal article